Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Return on Equity (2016 - 2025)

Historic Return on Equity for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 7.3%.

  • Jaguar Health's Return on Equity fell 47200.0% to 7.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.3%, marking a year-over-year decrease of 47200.0%. This contributed to the annual value of 6.89% for FY2024, which is 167700.0% up from last year.
  • Per Jaguar Health's latest filing, its Return on Equity stood at 7.3% for Q3 2025, which was down 47200.0% from 10.74% recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Return on Equity ranged from a high of 1.34% in Q2 2021 and a low of 43.15% during Q4 2022
  • Over the past 5 years, Jaguar Health's median Return on Equity value was 6.75% (recorded in 2023), while the average stood at 9.03%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -400000bps in 2022, then surged by 298800bps in 2023.
  • Over the past 5 years, Jaguar Health's Return on Equity (Quarter) stood at 3.15% in 2021, then crashed by -1270bps to 43.15% in 2022, then skyrocketed by 69bps to 13.27% in 2023, then skyrocketed by 70bps to 4.01% in 2024, then crashed by -82bps to 7.3% in 2025.
  • Its Return on Equity was 7.3% in Q3 2025, compared to 10.74% in Q2 2025 and 11.05% in Q1 2025.